ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19

PHASE2TerminatedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

March 24, 2021

Study Completion Date

May 31, 2021

Conditions
COVID-19
Interventions
DRUG

BI 764198

BI 764198

DRUG

Placebo

Placebo

Trial Locations (25)

15006

Hospital A Coruña, A Coruña

20230

Hospital Cardiologica Aguascalientes, Aguascalientes

28031

Hospital Universitario Infanta Leonor, Madrid

28040

Hospital Clínico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

43608

Mercy Health St. Vincent Medical Center, Toledo

64460

Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey

71301

Rapides Regional Medical Center, Alexandria

80230

"Hospital General de Culiacán Dr. Bernardo J. Gastellum", Culiacán

89227

Hospital Regional Hans Dieter Schmidt, Santa Catarina

92868

University of California Irvine, Orange

98201

Providence Regional Medical Center, Everett

98405

MultiCare Tacoma General Hospital, Tacoma

2341131

Hospital Carlos Van Buren, Valparaíso

8880465

Hospital Padre Alberto Hurtado, Santiago

02135

St. Elizabeth's Medical Center, Boston

02462

Newton-Wellesley Hospital, Newton

32380-490

Hospital Luxemburgo, Belo Horizonte

13060-080

IPECC - Instituto de Pesquisa Clínica de Campinas, Campinas

90160-092

Hospital Ernesto Dornelles, Porto Alegre

15090-000

Hospital de Base - Fac Med de Sao Jose do Rio Preto, São José do Rio Preto

00919

Hospital Auxilio Mutuo, Hato Rey

00936

Hospital Municipal de San Juan, Rio Piedras

03010

Hospital General Universitario de Alicante, Alicante

07120

Hospital Son Espases, Palma de Mallorca

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04604184 - ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 | Biotech Hunter | Biotech Hunter